Epilepsy Surgery in the First 3 Years of Life: Predictors of Seizure Freedom and Cognitive Development.


Journal

Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914

Informations de publication

Date de publication:
01 06 2019
Historique:
received: 21 02 2018
accepted: 18 07 2018
pubmed: 24 8 2018
medline: 2 4 2020
entrez: 24 8 2018
Statut: ppublish

Résumé

Although the majority of children undergoing epilepsy surgery are younger than 3 yr at epilepsy manifestation, only few actually receive surgical treatment in early childhood. Past studies have, however, suggested that earlier intervention may correlate with superior developmental outcomes. To identify predictors for long-term seizure freedom and cognitive development following epilepsy surgery in the first 3 yr of life and determine the appropriate timing for surgical treatment in this age group. We retrospectively analyzed the data of 48 consecutive children aged 1.1 ± 0.7 yr at surgery. Final surgeries comprised 52% hemispherotomies, 13% multilobar, and 35% intralobar resections. Etiology included cortical malformations in 71%, peri- or postnatal ischemic lesions in 13%, and benign tumor or tuberous sclerosis in 8% each. At last follow-up (median 4.3, range 1-14.3 yr), 60% of children remained seizure-free: 38% had discontinued antiepileptic drugs. Intralobar lesionectomy resulted more often in seizure control than multilobar or hemispheric surgery. Postsurgical seizure freedom was determined by the completeness of resection. Early postsurgical seizures were key markers of seizure recurrence. Presurgical adaptive and cognitive developmental status was impaired in 89% children. Longer epilepsy duration and larger lesion extent were detrimental to presurgical development, which, in turn, determined the postsurgical developmental outcome. Our study demonstrates that epilepsy surgery in very young children is safe as well as efficient regarding long-term seizure freedom and antiepileptic drug cessation in selected candidates. Longer epilepsy duration is the only modifiable predictor of impaired adaptive and cognitive development, thus supporting early surgical intervention.

Sections du résumé

BACKGROUND
Although the majority of children undergoing epilepsy surgery are younger than 3 yr at epilepsy manifestation, only few actually receive surgical treatment in early childhood. Past studies have, however, suggested that earlier intervention may correlate with superior developmental outcomes.
OBJECTIVE
To identify predictors for long-term seizure freedom and cognitive development following epilepsy surgery in the first 3 yr of life and determine the appropriate timing for surgical treatment in this age group.
METHODS
We retrospectively analyzed the data of 48 consecutive children aged 1.1 ± 0.7 yr at surgery.
RESULTS
Final surgeries comprised 52% hemispherotomies, 13% multilobar, and 35% intralobar resections. Etiology included cortical malformations in 71%, peri- or postnatal ischemic lesions in 13%, and benign tumor or tuberous sclerosis in 8% each. At last follow-up (median 4.3, range 1-14.3 yr), 60% of children remained seizure-free: 38% had discontinued antiepileptic drugs. Intralobar lesionectomy resulted more often in seizure control than multilobar or hemispheric surgery. Postsurgical seizure freedom was determined by the completeness of resection. Early postsurgical seizures were key markers of seizure recurrence. Presurgical adaptive and cognitive developmental status was impaired in 89% children. Longer epilepsy duration and larger lesion extent were detrimental to presurgical development, which, in turn, determined the postsurgical developmental outcome.
CONCLUSION
Our study demonstrates that epilepsy surgery in very young children is safe as well as efficient regarding long-term seizure freedom and antiepileptic drug cessation in selected candidates. Longer epilepsy duration is the only modifiable predictor of impaired adaptive and cognitive development, thus supporting early surgical intervention.

Identifiants

pubmed: 30137548
pii: 5077464
doi: 10.1093/neuros/nyy376
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

E368-E377

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 by the Congress of Neurological Surgeons.

Auteurs

Navah Ester Kadish (NE)

Department of Neuropediatrics, University Medical Centre Schleswig-Holstein, Kiel, Germany.
Department of Medical Psychology and Medical Sociology, University Medical Centre Schleswig-Holstein, Kiel, Germany.

Thomas Bast (T)

Epilepsy Centre Kork, Kehl-Kork, Germany.
Medical Faculty, University of Freiburg, Freiburg, Germany.

Gitta Reuner (G)

Section Neuropediatrics and Inborn Errors of Metabolism, University Children's Hospital, Heidelberg, Germany.

Kathrin Wagner (K)

Epilepsy Centre, University Hospital Freiburg, Germany.

Hans Mayer (H)

Epilepsy Centre Kork, Kehl-Kork, Germany.

Susanne Schubert-Bast (S)

Section Neuropediatrics and Inborn Errors of Metabolism, University Children's Hospital, Heidelberg, Germany.
Department of Neuropediatrics, Goethe- University, Frankfurt am Main, Germany.

Gert Wiegand (G)

Department of Neuropediatrics, University Medical Centre Schleswig-Holstein, Kiel, Germany.

Karl Strobl (K)

Epilepsy Centre Kork, Kehl-Kork, Germany.

Armin Brandt (A)

Epilepsy Centre, University Hospital Freiburg, Germany.

Rudolf Korinthenberg (R)

Division of Neuropediatrics and Muscular Disorders, Department of Paediatrics and Adolescent Medicine, University Hospital Freiburg, Germany.

Vera van Velthoven (V)

Department of Neurosurgery, University Hospital Freiburg, Germany.

Andreas Schulze-Bonhage (A)

Epilepsy Centre, University Hospital Freiburg, Germany.

Josef Zentner (J)

Department of Neurosurgery, University Hospital Freiburg, Germany.

Georgia Ramantani (G)

Medical Faculty, University of Freiburg, Freiburg, Germany.
Epilepsy Centre, University Hospital Freiburg, Germany.
Department of Neuropediatrics, University Children's Hospital Zürich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH